ARCHIVE

• Statement on Proper Use of Iressa Issued by JLCS
  November 24, 2003

• Ono: Sales Increase 2.8%, Profits Up 3.9%
  November 24, 2003

• Micardis Exerts Hypotensive Effects for 24-hour: JSH Meeting
  November 24, 2003

• Dainippon: Rapid Drop in Sales of Gatiflo Hurts Sales, Profits
  November 24, 2003

• Home Blood Pressure GL Compiled by JSH
  November 24, 2003

• Tanabe Seiyaku: 9.7% Increase in Net Profits Despite Sales Drop
  November 24, 2003

• NEW PRODUCTS
  November 24, 2003

• Shionogi: Sales Plunge 44.3%, but Profits Up
  November 24, 2003

• Japan Adult Guardianship Law Association Inaugurated
  November 24, 2003

• Chugai: Cost-cutting Efforts Produce Better-than-Expected Profits
  November 24, 2003

• REGULATORY NEWS IN BRIEF
  November 24, 2003

• Yamanouchi: Sales Up 2.8%, Attributable to Sales Growth of Harnal, Lipitor
  November 24, 2003

• Council for Regulatory Reform May Be Replaced with More Powerful Machine: Mr Miyauchi
  November 24, 2003

• Sankyo: Mevalotin Boosts Domestic, Overseas Sales
  November 24, 2003

• JCQHC Warns Against High-concentration K Preparations, 10% Xylocaine
  November 17, 2003

• Kyorin: Sales Down 3.3% due to Decline in Sales of Gatiflo
  November 17, 2003

• Japan's Pacemaker Market Growing Around 10% Annually
  November 17, 2003

• Fujisawa's Overseas Sales Exceed 50% of Total
  November 17, 2003

• BULLETIN
  November 17, 2003

• Semiannual Business Results
  November 17, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 562
• 563
• 564
• 565
• 566
• 567
• 568
• 569
• 570
• …
• Next ›
• 最終 »